The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Greece bans export of 25 drugs after pharmacists' supply warnings

Tue, 14th Jul 2015 17:14

(Adds AstraZeneca comment)

By Lefteris Karagiannopoulos

ATHENS, July 14 (Reuters) - Greece has decided to ban theexport of 25 types of drugs, the Health Ministry said onTuesday, following warnings of possible shortages that riskedleading to a humanitarian crisis.

A ministry spokeswoman quoted the Greek drugs regulator assaying there had been a significant increase in some importedmedicines being shipped back out of the country.

"Abuses by some players in the pharmaceuticals market havebeen discovered," she told Reuters.

The regulator made the warning on re-exports during ameeting at the Health Ministry on Friday, when pharmacistscomplained they faced difficulties in securing some supplies.

The spokeswoman said the ministry would closely checkexports and re-exports over the past 15 days and file complaintsat home and abroad where there is evidence of abuse. Shedeclined to say which drugs would be included in the ban.

However, the head of the drugs wholesalers' association saidthe group had not yet been informed of the ban.

The ban was the latest move in a row over the availabilityof drugs in Greece, with pharmacists, drugmakers, wholesalersand public authorities trading blame while rights group warn ofworsening public health conditions during the economic crisis.

Difficulties over drug supplies in Greece are compounded bycapital controls which prevent companies from sending moneyabroad, imposed last month to prevent the banking system fromcollapse.

Re-exporting drugs across European borders, which allowstraders to buy products in low-cost markets and sell them whereprices are higher, is permitted under European Union free traderules.

Drugmakers have nevertheless urged a curb on re-exports toprevent shortages in Greece but wholesalers trading medicineshave denied the need for such emergency action.

The European Federation of Pharmaceutical Industries andAssociations (EFPIA), which represents 40 drug companies, calledon Tuesday for "exceptional measures" in "exceptionalcircumstances".

"A proportionate, legislative ban on exporting medicinesintended for Greek patients from Greece would be an appropriateand justifiable response to possible shortages and help to averta potential humanitarian crisis," it said in a statement.

But the head of the Hellenic Association of MedicineWholesalers, Eirini Markaki, pointed the finger at internationaldrugmakers and pharmacists. "Most of the internationalpharmaceutical companies have issued quotas on the amount ofsupplies Greek warehouses can order," Markaki told Reuters.

"We have filed official complaints to the regulator so thatmeasures are taken for this to stop," she said, adding that thecomplaints targeted AstraZeneca, Novartis andJanssen, a unit of Johnson & Johnson. Novartis deniedthat it had limited its supplies to Greece, while Janssen wasnot immediately available for comment.

ASTRAZENECA DENIAL

A spokesperson for AstraZeneca said the firm had met theregulator last week "to dispute the allegations made by theHellenic Association of Pharmaceutical Warehouses".

At that meeting, AstraZeneca said, it had "provided evidenceto demonstrate that we continue to deliver in excess of thequantities of medicines currently required in the Greek market".

Markaki denied any overall increase in re-exports bywholesalers. She said an isolated case of one warehouseexporting 700,000 units of drugs in two days at the end of Junewas under investigation, but all the warehouses combined hadexported only 179,000 items so far in July.

Demand for drugs had increased because customers were tryingto build up their supplies, fearing future shortages, she added.

The pharmaceuticals industry is owed more than 1.1 billioneuros by Greek hospitals and the state-run health insurer inunpaid bills since December but it has promised to keep supplylines open on humanitarian grounds.

Separately, Greek pharmacists will go on strike on Wednesdayto protest about plans in a deal struck between Athens and itsinternational lenders on Monday to make changes to their trade.These include allowing people without a pharmacist's degree toopen a pharmacy. (Additional reporting by Kate Kelland in London; Writing byIngrid Melander; Editing by David Stamp)

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.